Recent comprehensive genomic analyses revealed a significant mRNA expression of PD‐L1 and PD‐L2 in EBV‐associated gastric adenocarcinoma, suggesting that, like MSI‐H tumors, these tumors are also sensitive to immune checkpoint inhibitors, such as Nivolumab.28, 31. This evidence concerns the gene CD274 and gastric adenocarcinoma.